Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Healthcare Services Mid (5.8bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (5.7bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.6bn) -1–5 -$100M+ -0–15% 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals & Medical Research Mid (5.6bn) 0 No activity — 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (5.5bn) 1–5 $10M–$100M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (5.5bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (5.3bn) -1–5 -$100K–$1M -0–15% 15–50%
US LHC Group Inc (LHCG)
Healthcare Services Mid (5.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (5.2bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 15–50%
GB Indivior PLC (INDV)
Pharmaceuticals & Medical Research Mid (4.9bn) 0 No activity — 0–15%
Healthcare Services Mid (4.7bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Mid (4.7bn) 0 No activity — 0–15%
US Veracyte Inc (VCYT)
Pharmaceuticals & Medical Research Mid (4.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Healthcare Services Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
US LivaNova PLC (LIVN)
Healthcare Services Mid (4.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.4bn) 0 No activity — 50%+
Healthcare Services Mid (4.4bn) 0 -< $100K 0–15% 0–15%
Healthcare Services Mid (4.4bn) -1–5 -$100M+ -15–50% 0–15%
Healthcare Services Mid (4.4bn) 0 No activity — 50%+
US Erasca Inc (ERAS)
Pharmaceuticals & Medical Research Mid (4.4bn) 0 No activity — 0–15%
US Celcuity Inc (CELC)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.3bn) 1–5 $100K–$1M 0–15% 15–50%
IN Biocon Ltd (BIOCON)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (4.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (4.2bn) 0 No activity — 0–15%
US RadNet Inc (RDNT)
Healthcare Services Mid (4.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Alkermes Inc (ALKS)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
US TESARO Inc (TSRO)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — —
US Metsera Inc (MTSR)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Healthcare Services Mid (4.1bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (4.0bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 No activity — 0–15%
Healthcare Services Mid (3.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.8bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Mid (3.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Perrigo Co (PRGO)
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Healthcare Services Mid (3.7bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (3.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.6bn) 0 No activity — 15–50%
Healthcare Services Mid (3.6bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.5bn) -1–5 -< $100K -0–15% 0–15%
US Organon & Co (OGN)
Pharmaceuticals & Medical Research Mid (3.5bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No activity — 50%+
Healthcare Services Mid (3.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (3.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (3.4bn) 0 No activity — 0–15%
Healthcare Services Mid (3.4bn) 0 No activity — 15–50%
SE Medicover AB (MCOV-B)
Healthcare Services Mid (3.4bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (3.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.3bn) 0 No activity — 0–15%
US Amedisys Inc (AMED)
Healthcare Services Mid (3.3bn) 0 No activity — 0–15%
Healthcare Services Mid (3.3bn) 0 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) -1–5 -< $100K -0–15% 0–15%
FR Virbac SA (VIRP)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 50%+
SE BioArctic AB (BIOA-B)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 15–50%
Healthcare Services Mid (3.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 1–5 $10M–$100M 0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 50%+
Healthcare Services Mid (3.2bn) -1–5 -$1M–$10M -0–15% 15–50%
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%